Physician

Abdul Qudoos Shahid, M.D.

According to 2025 Medicare claims, Abdul Shahid, M.D. (NPI: 1063496586) practices interventional pain management (ipm) in the Dayton-Kettering-Beavercreek, OH market, with the plurality of this provider's patient population coming from Montgomery, OH. This provider's primary affiliated billing organization is ANESTHESIA AND PAIN MANAGEMENT LLC (NPI: 1053600114; TIN: 770721566) and primary practice location at 45431-3840.

Shahid's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 224 traditional Medicare patients, billed 1,894 HCPCS/CPT codes, and received $126,049 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 355 prescription claims across 109 beneficiaries totaling $5,027 in drug costs, led by Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen). Open Payments data shows 8 records totaling $353. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $136,197 and ending at $126,049. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $108,442 to $5,027. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	262	3,456	$136,197
2016	309	3,809	$156,570
2017	187	2,374	$102,658
2018	184	2,687	$182,978
2019	210	2,927	$213,692
2020	208	2,533	$170,444
2021	235	2,118	$164,041
2022	211	1,369	$91,938
2023	202	1,035	$78,544
2024	224	1,894	$126,049

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	342	2,781	$108,442
2016	370	1,838	$73,801
2017	120	355	$17,046
2018	282	1,263	$52,769
2019	270	1,062	$58,049
2020	231	658	$20,401
2021	104	251	$3,468
2022	104	288	$5,609
2023	122	404	$8,858
2024	109	355	$5,027

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	62	62	$108
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	170	517	$92
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	105	200	$63
80307	Testing for presence of drug, by chemistry analyzers	191	337	$59
J1100	Injection, dexamethasone sodium phosphate, 1 mg	38	215	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	77	1,609	$1,480
Cephalexin	Cephalexin	29	390	$660
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	35	685	$358
Gabapentin	Gabapentin	47	1,267	$328
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	22	545	$234

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	7	$353	Abbott Laboratories
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	1	$25,000	AxioMed LLC

Explore More Providers

FAQ

What Medicare data is available for Abdul Qudoos Shahid, M.D.?

Tedicare shows public-source Medicare data for Abdul Qudoos Shahid, M.D. (NPI 1063496586), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abdul Qudoos Shahid, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Abdul Qudoos Shahid, M.D.?

Abdul Qudoos Shahid, M.D. is linked to ANESTHESIA AND PAIN MANAGEMENT LLC (billing NPI 1053600114) in the available physician profile data.

Does Abdul Qudoos Shahid, M.D. have Open Payments data?

Abdul Qudoos Shahid, M.D. has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.